MaxWin International Holdings Limited

MaxWin International Holdings Limited

HHKEX:8513
0.32
HKD
0.00
(0.00%)
92.08MMarket Cap
MaxWin International Holdings Limited
HKEX:8513
(Hong Kong Exchange)

Recent

price

0.32

P/E

ratio

- -

div

yld

- -

ROIC.AI

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
SGD
0.44
0.48
0.52
0.42
0.33
0.5
0.43
0.26
0.16
0.14
0.23
- -
Revenue per Share
0.03
0.04
-0.02
-0.08
-0.04
0.02
-0.15
-0.06
-0.12
-0.04
-0.01
- -
Basic EPS, GAAP
0.07
0.03
-0.04
-0.06
- -
0.06
0.07
-0.03
-0.02
-0.02
- -
- -
Free Cash Flow per Basic Share
- -
- -
0.03
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.03
0.08
0.07
0.24
0.2
0.37
0.21
0.15
0.04
0.03
0.02
0.02
Book Value per Share
0.03
0.07
0.07
0.24
0.2
0.21
0.21
0.15
0.04
0.03
0.02
0.02
Tangible Book Value per Share
40
40
40
40
46
46
46
53
57
74
82
60
Basic Weighted Avg Shares
18
19
21
17
15
23
20
14
9
10
19
- -
Sales/Revenue/Turnover
9.05
12.03
-2.07
-16.64
-10.68
8.37
2.5
-16.15
-38.72
-18.97
1.46
- -
Operating Margin (%)
1
1
1
1
2
2
3
2
2
2
1
- -
Depreciation Expense
1
2
-1
-3
-2
1
-7
-3
-7
-3
-1
- -
Net Income, GAAP
18.86
16.88
- -
- -
- -
22.58
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
6.14
8.84
-3.96
-18.8
-10.91
3.38
-35.66
-21.1
-73.75
-25.16
-3.29
- -
Profit Margin (%)
- -
2
2
8
5
8
9
7
1
3
- -
- -
Working Capital
- -
- -
- -
- -
3
3
1
1
2
2
1
1
LT Debt
1
3
3
10
8
18
11
9
3
2
2
1
Total Equity
- -
30.51
- -
- -
- -
8.44
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
32.39
- -
- -
- -
5.9
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
77.76
-28.2
-49.7
-18.81
6.23
-51.71
-31.28
-117.02
-104.72
-33.4
- -
Return on Common Equity (%)

Capital Structure

SGD

•

in mil. unless spec.
Sep'23
Dec'23
Jun'24
ST Debt
- -
3
4
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
2
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
57
68
68
Market Capitalization
14
8
16

Working Capital

SGD

•

in mil. unless spec.
Sep'23
Dec'23
Jun'24
Total Current Assets
- -
6
6
Cash, Cash Equivalents & STI
- -
2
1
Accounts Receivable, Net
- -
2
3
Inventories
- -
1
1
Total Current Liabilities
- -
5
6
Payables & Accruals
- -
- -
- -
ST Debt
- -
3
4
Deferred Revenue
- -
- -
- -

Growth Rates

SGD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
28.99%
-35.56%
-29.02%
Free Cash Flow
-205.16%
-55.03%
-125.95%
Net Income, GAAP
-107.6%
-213.11%
-76.74%
Sales/Revenue/Turnover
5.43%
2.67%
77.7%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
10
2025
- -
- -
19
2026
- -
- -
- -

Semi-annual Earnings Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.04
2025
- -
- -
-0.01
2026
- -
- -
- -

Semi-annual Dividends Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Business
MaxWin International Holdings Limited, an investment holding company listed on the Hong Kong Stock Exchange's GEM board (ticker: 8513.HK), manufactures and sells injection-molded plastic parts for disposable medical devices and provides tooling services; its core offerings include component parts and sub-assembly parts for applications such as respiratory products, dialysis products, blood bag products, drug delivery products, diagnostic tools, and microfluidics; it also produces plastic articles and products through subsidiaries like Inzign Pte Ltd, Medizign Pte Ltd, and P.T. Inzign. The company operates primarily in Singapore, with manufacturing and sales extending to Asia and Europe, targeting multinational medical device corporations from the United States, Europe, and Japan. Founded in 1981 and headquartered at 16 Kallang Place, #02-10, Singapore 339156, it maintains a workforce of approximately 88-94 employees focused on production, quality assurance, engineering, and management. Recent developments include a name change from IAG Holdings Limited to MaxWin International Holdings Limited in October 2023; disposal of its non-core amusement machines and equipment segment via sale of Savour Talent Global Limited and subsidiaries in December 2023 for HK$0.3 million to refocus on medical plastics; a share placement in July 2024 raising net proceeds of HK$9.7 million from 136 million new shares at HK$0.072 each for general working capital; board changes with appointments of executive directors such as Li Rengang in October 2024 and Yang Qijun in November 2024, alongside resignations; and a proposed 10:1 share consolidation announced in December 2025, reducing issued shares from 818 million to 81.8 million while changing the board lot size from 20,000 to 5,000 shares. In FY2024 ended December 31, revenue rose 15% to S$10.5 million with gross profit turning positive at S$0.2 million, driven by operational efficiencies, though net loss narrowed to S$2.6 million.